PZ Cormay S.A. (WSE:CRM)

Market Cap	43.79M
Revenue (ttm)	87.01M
Net Income (ttm)	-6.31M
Shares Out	84.21M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,035
Average Volume	37,277
Open	0.5100
Previous Close	0.5160
Day's Range	0.5100 - 0.5220
52-Week Range	0.3550 - 0.6300
Beta	1.04
RSI	47.58
Earnings Date	Mar 28, 2025

About PZ Cormay

PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, electrophoresis, hematology, veterinary, coagulology, blood group serology, immunology, immunochemistry, molecular biology, sampling, oncological surgery, and general analytics, as well as vacuum blood collection system. The company offers its products under the Orphée and Diesse brand names. The company also exports its products to approximately 150 countries, including Germany, Austria, France, Greece, Turkey, Ind...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1985
• Employees: 225
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: CRM

Financial Performance

In 2023, PZ Cormay's revenue was 82.23 million, a decrease of -3.67% compared to the previous year's 85.36 million. Losses were -4.50 million, -35.43% less than in 2022.